The Usefulness of the Discrete Choice Experiment in Providing Effective Healthcare by Nikolina Dukić

“…As public healthcare is characterized by administrative decision-making and relying on non-market mechanisms in the resource allocation, it requires the implementation of economic evaluations. This discussion shows that because the specifics of public healthcare complicate the data collection of revealed (market) preferences, it is necessary to rely on stated preferences of respondents in order to evaluate the economic value of health interventions as well to improve public health care interventions and make them more patients oriented. …”
Get full text

Strategies for introducing and implementing vaccines for adults into national immunization programs in Europe: Good practices and key insights of the adult immunization board meeti... by Sara Boccalini, Angela Bechini, Marco Del Riccio, Birgit Weinberger, Jacek Wysocki, Domenico Martinelli, Ole Wichmann, Tiina Likki, Greet Hendrickx, Pierre Van Damme, Chloé Wyndham-Thomas, Paolo Bonanni, Jade Pattyn

“…In Europe, burden of disease, vaccine efficacy or effectiveness, and safety are universally used decision-making criteria. While economic evaluations and the quality of evidence are being increasingly considered, public acceptance, equity, and operational criteria remain underutilized. …”
Get full text

Cost Management at Higher Education Institutions – Cases of Bosnia and Herzegovina, Croatia and Slovenia by Martina Dragija Kostić, Tatjana Jovanović, Jelena Jurić

“…This caused repeated calls for reforms of the economic model in the higher education sector and dramatically increased the importance of the economic evaluations in the last decades due to concerns for efficiency. …”
Get full text

Portable wide-field digital imaging for screening of neonatal visual impairment causes in Rio de Janeiro, Brazil: a budget impact analysis by Andrea Zin, Lorena M Haefeli, Luiza M Neves, Ana Carolina Carioca Costa, Zilton Farias Meira de Vasconcelos, Marcia Pinto

“…Further health economic evaluations should be performed to verify the affordability of the implementation of this screening strategy in the Brazilian scenario, taking into account scarce human resources.…”
Get full text

The Cost of an Operating Room Minute for Heart Valve Procedures by Eugene A. Grossi, Matthew Moore, Peter J. Mallow, John A. Rizzo

“…**Conclusions:** Quantifying the variable cost of an OR minute from a multi-institution database provides researchers with an important benchmark to use in economic evaluations of valvular procedures.…”
Get full text

Nonsevere Hypoglycemia Episode Clinical and Economic Outcomes: A Comparison between Sulfonylurea and Sodium-Glucose Cotransporter 2 Inhibitor as Add-On to Metformin from a Canadian... by Pendar Farahani

“…NSHE, which is a forgotten variable in economic evaluations for healthcare reimbursement models, occurs frequently in real-world clinical settings but is infrequently reported. …”
Get full text

Cost-effectiveness of Public Health Strategies on COVID-19 Control: A Systematic Review by Ajaree Rayanakorn, Siew Lian Leong, Pattaranai Chaiprom, Shaun Wen Huey Lee

“…This systematic review aimed to provide a critical summary of full economic evaluations (EEs) to inform decisions concerning their adoptions. …”
Get full text

Pore Structure and Fluid Uptake of the Springer/Goddard Shale Formation in Southeastern Oklahoma, USA by Qinhong Hu, Wen Zhou, Paul Huggins, Wenling Chen

“…A petrophysical analysis of the Springer shale presented in this work is beneficial to further understand the pore structure and fluid movement within the shale to facilitate increased production and accurate economic evaluations.…”
Get full text

A framework for quantifying the multisectoral burden of animal disease to support decision making by Sara Lysholm, Sara Lysholm, Gemma L. Chaters, Gemma L. Chaters, Carlotta Di Bari, Carlotta Di Bari, Ellen C. Hughes, Ellen C. Hughes, Ben Huntington, Ben Huntington, Jonathan Rushton, Jonathan Rushton, Lian Thomas, Lian Thomas

“…This approach aligns with the One Health concept, which seeks to integrate and optimize the health of humans, animals and the environment. Traditional economic evaluations often focus narrowly on profit maximization within the livestock sector, neglecting wider externalities such as public health and environmental impacts. …”
Get full text

The Two-Tier Fecal Occult Blood Test: Cost-Effective Screening by Andrew J Rae, Iain GM Cleator

“…This initial study, focusing on the cost-benefit relationship of increased specificity, represents a new way of economically evaluating existing FOBTs.…”
Get full text

JAK2 V617F as a Marker for Long-Term Disease Progression and Mortality in Polycythemia Vera and its Role in Economic Modeling by Jonas Hjelmgren, Kristoffer Nilsson, Gunnar Birgegård

“…**Background:** In order to facilitate sound economic evaluations of novel treatments, health-economic models of polycythemia vera (PV) must combine effects on surrogate endpoints in trials with disease progression (DP) and mortality in long-term cohort data. …”
Get full text

Real-World Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in France by Huamao Mark Lin, Keith L. Davis, James A. Kaye, Katarina Luptakova, Saurabh P. Nagar, Mohamad Mohty

“…These findings may inform economic evaluations of RRMM therapies.…”
Get full text

Are Trends in Economic Modeling of Pediatric Diabetes Mellitus up to Date with the Clinical Practice Guidelines and the Latest Scientific Findings? by Roque Cardona-Hernandez, Alberto de la Cuadra-Grande, Julen Monje, María Echave, Itziar Oyagüez, María Álvarez, Isabel Leiva-Gea

“…**Methods:** A literature review was performed in March 2023 to identify modeling-based economic evaluations in diabetes in pediatric patients. Data were extracted and synthesized from eligible studies. …”
Get full text

Matching plus regression adjustment for the estimation of the average treatment effect on survival outcomes: a case study with mosunetuzumab in relapsed/refractory follicular lymph... by Danilo Di Maio, S. A. Mitchell, S. Batson, E. Keeney, Howard H. Z. Thom

“…Abstract Background and objectives The National Institute for Health and Care Excellence (England’s health technology assessment body) recommend the use of the average treatment effect (ATE) as an estimand for economic evaluations. However there is limited literature on methods to estimate the ATE, particularly in the case of survival outcomes. …”
Get full text

Effectiveness of Single-Tablet Combination Therapy in Improving Adherence and Persistence and the Relation to Clinical and Economic Outcomes by Carly J. Paoli, Jörg Linder, Khushboo Gurjar, Deepika Thakur, Julie Wyckmans, Stacy Grieve

“…**Objectives:** We conducted a systematic literature review (SLR) to examine STCT-associated outcomes across 4 evidence domains: clinical trials, real-world evidence (RWE), health-related quality of life (HRQoL) studies, and economic evaluations. **Methods:** Four SLRs were conducted across the aforementioned domains. …”
Get full text

An Insurance Value Modeling Approach That Captures the Wider Value of a Novel Antimicrobial to Health Systems, Patients, and the Population by Mei S. Chan, Richard Holloway, Robert King, Rosie Polya, Rebecca Sloan, Jack C. Kowalik, Tom Ashfield, Luke S.P. Moore, Thomas Porter, Jonathan Pearson-Stuttard

“…**Background:** Traditional health economic evaluations of antimicrobials currently underestimate their value to wider society. …”
Get full text

Estimating the Health-Related Quality of Life Benefit of Prophylactic Treatment for COVID-19 in Immunocompromised People: A Multimethod Valuation Study by Katy Gallop, Rebekah Hall, Michael Watt, Daniel Squirrell, Neil Branscombe, Sofie Arnetop, Andrew Lloyd

“…**Objective:** To estimate the potential HRQoL and utility benefit of PrEP for prevention of COVID-19 in individuals with IC conditions who may not have an adequate response of full vaccination (and therefore are at “highest risk” of severe COVID-19) that can be used in future economic evaluations of preventative therapies against COVID-19. …”
Get full text

Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study by Yi Hsuan Chen, Michiel Kroesen, Mischa Hoogeman, Matthijs Versteegh, Carin Uyl-de Groot, Hedwig M. Blommestein

“…This study provided estimation of each radiation-related toxicity, including xerostomia, dysphagia, mucositis, and dermatitis, which could contribute to the value assessment through economic evaluations of PT.…”
Get full text

Economic impact of medication non-adherence by disease groups: a systematic review by Victoria Garcia-Cardenas, Rachelle Louise Cutler, Fernando Fernandez-Llimos, Michael Frommer, Charlie Benrimoj

“…Drummond quality assessment yielded 10 studies of high quality with all studies performing partial economic evaluations to varying extents.Conclusion Medication non-adherence places a significant cost burden on healthcare systems. …”
Get full text

Improving future fish consumption: A case study on developing fish products for preschool children by Hui Jia, Zdeněk Fuka, Jan Hora, Magdalena Marešová, Věra Adámková, Koushik Roy, Jan Mraz

“…The omega-3 fatty acid content (Eicosapentaenoic Acid (EPA) + Docosahexaenoic Acid (DHA) 265 mg/ 100 g in fish ham to 1067 mg/ 100 g in fish sausages) exceeded recommended daily intake of EPA+DHA (>100 %; average 233 %), underscoring health benefits, especially from other boneless parts of fish beyond just fillets. Economic evaluations indicated that production costs varied (cost: 3.69–7.19 USD/kg, price: 5.51–10.71 USD/kg excluding taxes) inversely with the use of fish fillets versus fish baader. …”
Get full text